Effect modification by transferrin C2 polymorphism on lead exposure, hemoglobin levels, and IQ

NeuroToxicology

Volumn 38, Issue , 2013, Pages 17-22

  Roy, Ananya ^a   Ettinger, Adrienne S ^a,b   Hu, Howard ^c   Bellinger, David ^b,d   Schwartz, Joel ^b   Modali, Rama ^e   Wright, Robert O ^b,f   Palaniappan, Kavitha ^g   Balakrishnan, Kalpana ^h  

^a YALE UNIVERSITY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Bioserve   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF NEWCASTLE   (Australia)

^h SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Genotype; Hemoglobin; Intelligence quotient (IQ); Iron; Lead; Transferrin

Indexed keywords

HEMOGLOBIN; LEAD; TRANSFERRIN;

ALLELE; ARTICLE; BINET KAMATH SCALE OF INTELLIGENCE; CHILD; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HEMOGLOBIN BLOOD LEVEL; HOMOZYGOTE; HUMAN; INDIA; INTELLIGENCE QUOTIENT; LEAD BLOOD LEVEL; MALE; MOLECULAR INTERACTION; PRIORITY JOURNAL; RATING SCALE; SCHOOL CHILD; TRANSFERRIN GENE; WILD TYPE;

GENOTYPE; HEMOGLOBIN; INTELLIGENCE QUOTIENT (IQ); IRON; LEAD; TRANSFERRIN;

CHILD; CHILD, PRESCHOOL; ENVIRONMENTAL EXPOSURE; FEMALE; GENOTYPE; HEMOGLOBINS; HUMANS; INDIA; INTELLIGENCE; INTELLIGENCE TESTS; LEAD; MALE; POLYMORPHISM, GENETIC; TRANSFERRIN;

EID: 84879561158     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2013.05.005     Document Type: Article

References (58)

1. Bartzokis G., Lu P.H., Tishler T.A., Peters D.G., Kosenko A., Barrall K.A., et al. Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men. J Alzheimers Dis 2010, 20:333.
2. Beard J.L., Felt B., Schallert T., Burhans M., Connor J.R., Georgieff M.K. Moderate iron deficiency in infancy: biology and behavior in young rats. Behav Brain Res 2006, 170(2):224-232.
3. Beard J. Recent evidence from human and animal studies regarding iron status and infant development. J Nutr 2007, 137(2):524S-530S.
4. Beckman L., Beckman G. Transferrin C2 as an enhancer of cyto- and genotoxic damage. Prog Clin Biol Res 1986, 209b:221.
5. Bradley R.H., Caldwell B.M. The HOME inventory and family demographics. Dev Psychol 1984, 20:315-320.
6. Bressler J.P., Olivi L., Cheong J.H., Kim Y., Bannona D. Divalent metal transporter 1 in lead and cadmium transport. Ann N Y Acad Sci 2004, 1012:142-152.
7. Brubaker C.J., Schmithorst V.J., Haynes E.N., Dietrich K.N., Egelhoff J.C., Lindquist D.M., et al. Altered myelination and axonal integrity in adults with childhood lead exposure: a diffusion tensor imaging study. Neurotoxicology 2009, 30:867-875.
8. Cantonwine D., Hu H., Tellez-Rojo M.M., Sanchez B.N., Lamadrid-Figueroa H., Ettinger A.S., et al. HFE gene variants modify the association between maternal lead burden and infant birthweight: a prospective birth cohort study in Mexico City. Mexico Environ Health 2010, 9:43.
9. Cecil K.M. Effects of early low-level lead exposure on human brain structure, organization and functions. J Dev Orig Health Dis 2011, 2:17-24.
10. Centers for Disease Control and Prevention (CDC) Recommendations to prevent and control iron deficiency in the United States. MMWR 1998, 47(RR-3):1-36.
11. Cleve H., Schwendner E., Rodewald A., Bidlingmaier F. Genetic transferrin types and iron-binding: a comparative study of a European and an African population sample. Hum Genet 1988, 78:16.
12. Collins F.S., Brooks L.D., Chakravarti A. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res 1998, 8:1229-1231.
13. Congdon E.L., Westerlund A., Algarin C.R., Peirano P.D., Gregas M., Lozoff B., et al. Iron deficiency in infancy is associated with altered neural correlates of recognition memory at 10 years. J Pediatr 2012, 160:1027-1033.
14. Cory-Slechta D.A. Relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic, and glutamatergic neurotransmitter system functions. Annu Rev Pharmacol Toxicol 1995, 35:391-415.
15. Cory-Slechta D.A. Legacy of lead exposure: consequences for the central nervous system. Otolaryngol Head Neck Surg 1996, 114(2):224-226.
16. Cory-Slechta D.A. Relationships between Pb-induce changes in neurotransmitter system function and behavioral toxicity. Neurotoxicology 1997, 18(3):673-688.
17. Hanson E.H., Imperatore G., Burke W. HFE gene and hereditary hemochromatosis a huge review. Am J Epidemiol 2001, 154(3):193-206.
18. Heilig E., Molina R., Donaghey T., Brain J.D., Wessling-Resnick M. Pharmacokinetics of pulmonary manganese absorption: evidence for increased susceptibility to manganese loading in iron-deficient rats. Am J Physiol Lung Cell Mol Physiol 2005, 288:L887-L893.
19. Hoefkens P., Huijskes-Heins M.I., de Jeu-Jaspars C.M., van Noort W.L., van Eijk H.G. Influence of transferrin glycans on receptor binding and iron-donation. Glycoconj J 1997, 14:289-295.
20. Hopkins M.R., Ettinger A.S., Hernandez-Avila M., Schwartz J., Tellez-Rojo M.M., Lamadrid-Figueroa H., et al. Variants in iron metabolism genes predict higher blood lead levels in young children. Environ Health Perspect 2008, 116:1261-1266.
21. National Family Health Survey (NHFS-3) 2005-2006 2007, International Institute for Population Sciences and Macro International.
22. Kamat V.V. Measuring intelligence of Indian children 1967, Oxford University Press, Mumbai.
23. Kauwe J.S., Bertelsen S., Mayo K., Cruchaga C., Abraham R., Hollingworth P., et al. Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 2010, 153B::955-959.
24. Kohno H., Taketani S., Tokunaga R. The effect of lead on iron uptake from transferrin in human erythroleukemia (K562) cells. Biometals 1993, 6:77-83.
25. Kordas K. Iron, lead, and children's behavior and cognition. Annu Rev Nutr 2010, 30:123-148.
26. Kutalik Z., Benyamin B., Bergmann S., Mooser V., Waeber G., Montgomery G.W., et al. Genome-wide association study identifies two loci strongly affecting transferrin glycosylation. Hum Mol Genet 2011, 20:3710.
27. Kwong W.T., Friello P., Semba R.D. Interactions between iron deficiency and lead poisoning: epidemiology and pathogenesis. Sci Total Environ 2004, 330:21-37.
28. Landeghem G.F.V., Sikström C., Beckman L.E., Adolfsson R., Beckman L. Transferrin C2, metal binding and Alzheimer's disease. Neuroreport 1998, 9:177.
29. Lanphear B.P., Hornung R., Khoury J., Yolton K., Baghurst P., Bellinger D.C., et al. Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect 2005, 113:894.
30. Lehmann D.J., Worwood M., Ellis R., Wimhurst V.L., Merryweather-Clarke A.T., Warden D.R., et al. Iron genes, iron load and risk of Alzheimer's disease. J Med Genet 2006, 43:52.
31. Lehmann D.J., Schuur M., Warden D.R., Hammond N., Belbin O., Kolsch H., et al. Transferrin and HFE genes interact in Alzheimer's disease risk: the epistasis project. Neurobiol Aging 2012, 33(202e1,):20213.
32. Lozoff B. Early iron deficiency has brain and behavior effects consistent with dopaminergic dysfunction. J Nutr 2011, 141. 740S-6S.
33. Moos T. Brain iron homeostasis. Dan Med Bull 2002, 49:279-301.
34. Osendarp S.J., Murray-Kolb L.E., Black M.M. Case study on iron in mental development - in memory of John Beard (1947-2009). Nutr Rev 2010, 68(Suppl 1):S48-S52.
35. Ortiz E., Pasquini J.M., Thompson K., Felt B., Butkus G., Beard J., et al. Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J Neurosci Res 2004, 77:681-689.
36. Palaniappan K., Roy A., Balakrishnan K., Gopalakrishnan L., Mukherjee B., Hu H., et al. Lead exposure and visual-motor abilities in children from Chennai, India. Neurotoxicology 2011, 32:465-470.
37. Park S.K., Hu H., Wright R.O., Schwartz J., Cheng Y., Sparrow D., et al. Iron metabolism genes, low-level lead exposure, and QT interval. Environ Health Perspect 2009, 117:80-85.
38. Qaqish B.F., Liang K.Y. Marginal models for correlated binary responses with multiple classes and multiple levels of nesting. Biometrics 1992, 48:939-950.
39. Qian Z.M., Morgan E.H. Effect of lead on the transport of transferrin-free and transferrin-bound iron into rabbit reticulocytes. Biochem Pharmacol 1990, 40:1049-1054.
40. Robson K.J., Lehmann D.J., Wimhurst V.L., Livesey K.J., Combrinck M., Merryweather-Clarke A.T., et al. Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease. J Med Genet 2004, 41:261-265.
41. Rosner B. Percentage points for generalized ESD many-outlier procedure. Technometrics 1983, 25:165.
42. Roy A., Bellinger D., Hu H., Schwartz J., Ettinger A.S., Wright R.O., et al. Lead exposure and behavior among young children in Chennai, India. Environ Health Perspect 2009, 117:1607-1611.
43. Roy A., Hu H., Bellinger D.C., Palaniapan K., Wright R.O., Schwartz J., et al. Predictors of blood lead in children in Chennai, India (2005-2006). Int J Occup Environ Health 2009, 15:351-359.
44. Roy A., Hu H., Bellinger D.C., Mukherjee B., Modali R., Nasaruddin K., et al. Hemoglobin, lead exposure, and intelligence quotient: effect modification by the DRD2 Taq IA polymorphism. Environ Health Perspect 2011, 119:144-149.
45. Seifer R Socioeconomic status, multiple risks and development of intelligence. Environmental Effects on Cognitive Abilities 2001, 59-82. Lawrence Erlbaum Associates, Mahwah, NJ. R.J. Sternberg, E.L. Grigorenko (Eds.).
46. Shannon M., Rifai N. The accuracy of a portable instrument for analysis of blood lead in children. Ambul Child Health 1997, 3:249-254.
47. Sikström C., Beckman L., Hallmans G., Asplund K. Transferrin types, iron-binding capacity and body iron stores. Hum Hered 1993, 43:337.
48. Stoltzfus R.J., Heidkamp R., Kenkel D., Habicht J.P. Iron supplementation of young children: learning from the new evidence. Food Nutr Bull 2007, 28:S572-S584.
49. Todorich B., Pasquini J.M., Garcia C.I., Paez P.M., Connor J.R. Oligodendrocytes and myelination: the role of iron. Glia 2008, 57(5):467-478.
50. van Rensburg S.J., Berman P., Potocnik F., MacGregor P., Hon D., de Villiers N. 5- and 6-glycosylation of transferrin in patients with Alzheimer's disease. Metab Brain Dis 2004, 19:89.
51. Wang F.T., Hu H., Schwartz J., Weuve J., Spiro A.S., Sparrow D., et al. Modifying effects of the HFE polymorphisms on the association between lead burden and cognitive decline. Environ Health Perspect 2007, 115:1210-1215.
52. Wong C.T., Saha N. Effects of transferrin genetic phenotypes on total iron-binding capacity. Acta Haematol 1986, 75:215.
53. Wright R.O., Silverman E.K., Schwartz J., Tsaih S.W., Senter J., Sparrow D., Weiss S.T., Aro A., Hu H. Association between hemochromatosis genotype and lead exposure among elderly men: the normative aging study. Environ Health Perspect. 2004, 112(6):746-750.
54. Wright R.O., Tsaih S.W., Schwartz J., Wright R.J., Hu H. Association between iron deficiency and blood lead level in a longitudinal analysis of children followed in an urban primary care clinic. J Pediatr 2003, 142:9-14.
55. Zatta P., Messori L., Mauri P., van Rensburg S.J., van Zyl J., Gabrielli S., et al. The C2 variant of human serum transferrin retains the iron binding properties of the native protein. Biochim Biophys Acta 2005, 1741:264.
56. Zhang A., Park S.K., Wright R.O., Weisskopf M.G., Mukherjee B., Nie H., et al. HFE H63D polymorphism as a modifier of the effect of cumulative lead exposure on pulse pressure: the normative aging study. Environ Health Perspect 2010, 118:1261-1266.
57. Zimmermann M.B., Muthayya S., Moretti D., Kurpad A., Hurrell R.F. Iron fortification reduces blood lead levels in children in Bangalore, India. Pediatrics 2006, 117:2014-2021.
58. Zuch C.L., O'Mara D.J., Cory-Slechta D.A. Low-level lead exposure selectively enhances dopamine overflow in nucleus accumbens: an in vivo electrochemistry time course assessment. Toxicol Appl Pharmacol 1998, 150(1):174-185.